(1)
CHANGES IN INSTRUMENTAL TESTS AT DIFFERENT LEVELS OF TRIMETHYLAMINE-N-OXIDE IN PATIENTS WITH ISCHEMIC HEART DISEASE. ibmscr 2024, 4 (4), 5-7.